Form CORRESP - Correspondence:
SEC Accession No. 0001213900-24-076607
Filing Date
2024-09-06
Accepted
2024-09-06 17:15:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7391
2 GRAPHIC image_001.jpg GRAPHIC 5580
  Complete submission text file 0001213900-24-076607.txt   16278
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)